SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients
- Conditions
- Sars-CoV2Tear
- Interventions
- Diagnostic Test: Tears swab
- Registration Number
- NCT04402853
- Lead Sponsor
- Università degli Studi dell'Insubria
- Brief Summary
Observational study to evaluate the presence of SARS COV-2 in tears collected in COVID-19 patients in Lombardia region, northern Italy, and to correlate virus presence to concomitant systemic clinical conditions.
- Detailed Description
Since February 2020, Coronavirurus Disease 2019 associated to a severe acute respiratory syndrome started in China and rapidly spread all over the world and in particular in northern Italy. There are many reasons to justify this rapid diffusion in Italian Lombardia region as the high population density with more possibilities of interpersonal contact, high prevalence of respiratory pathologies, in particular in elderly people, due to pollution, high number of contacts with Chinese population for travelling and business reasons, and at last the non-windy temperate climate conditions, that increases the persistence of virus in the environment.
At now, more than eighty thousand citizens from Lombardia Region have been officially affected by the disease with a high death toll, also considering that actual numbers are certainly much underestimated.
The aim of the present study was to evaluate the prevalence of SARS COV-2 virus in tears collected from COVID-19 patients by rtPCR analysis directed to target sites of viral RNA, and to correlate virus presence to concomitant systemic clinical conditions
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Hospitalized COVID 19 patients
- Patients with respiratory support that interferes with tears sampling
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID 19 Patients Tears swab hospitalized patients with COVID 19
- Primary Outcome Measures
Name Time Method Virus presence in COVID 19 patients tears 1 day prevalence of SARS CoV 2 virus on tears
- Secondary Outcome Measures
Name Time Method Concordance to Naso-Pharingeal Swab 1 day Evaluation of concordance with Naso-Pharingeal testing
Trial Locations
- Locations (1)
ASST Sette Laghi
🇮🇹Varese, Italy